51.05
-3.38 (-6.21%)
| Previous Close | 54.43 |
| Volume | 248,687 |
| Price / Sales | 3.04 |
| Price / Book | 37.95 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.990 |
| Total Debt/Equity (MRQ) | 7.24% |
| Current Ratio (MRQ) | 15.58 |
| Operating Cash Flow (TTM) | -40.08 M |
| Levered Free Cash Flow (TTM) | -19.59 M |
| Return on Assets (TTM) | -43.61% |
| Return on Equity (TTM) | -77.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | Pulse Biosciences, Inc | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 3.5 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 1.75 |
|
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 74.00% |
| % Held by Institutions | 8.62% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Griffin Asset Management, Inc. | 30 Jun 2026 | 227,285 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| TEPLITSKY LIANE RAE | 51.21 | - | 2,025 | 103,680 |
| Aggregate Net Quantity | 2,025 | |||
| Aggregate Net Value ($) | 103,680 | |||
| Aggregate Avg. Buy ($) | 51.21 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| TEPLITSKY LIANE RAE | Officer | 01 Sep 2026 | Buy (+) | 1,001 | 52.09 | 52,142 |
| TEPLITSKY LIANE RAE | Officer | 31 Aug 2026 | Buy (+) | 1,024 | 50.33 | 51,538 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |